Pharmaceutical Industry Information Portal

HomeRegulatory News

Regulatory News

Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis

At this point in time, no causal relationship with myocarditis or pericarditis could be established with two other COVID-19 vaccines authorised in the EEA, COVID-19 Vaccine Janssen and Vaxzevria.

The European Parliament proposed to expand the powers of the EMA

Parliament wants to strengthen the transparency of both the Agency and all actors in the supply chain, and give a more active role to healthcare professionals, as well as encouraging synergies between EU agencies.

Entry into Force of PIC/S Guidance on Good Practices for Data Management and Integrity

The guidance has been developed primarily for inspectors, but also serves as a valuable resource for industry to provide clarity on areas of greatest risk and regulatory expectations.

WHO recommends life-saving interleukin-6 receptor blockers for COVID-19

Interleukin-6 blocking drugs – tocilizumab and sarilumab – act to suppress this overreaction. WHO has launched an expression of interest for prequalification of manufacturers of interleukin-6 receptor blockers.

Vector Center applies for registration of its vaccine EpiVacCorona-N

An application for the registration of the anti-COVID vaccine EpiVacCorona-N has been submitted to the Russian Health Ministry for registration, as follows from a...

Latest patent reforms to further bolster innovative pharma research in China

According to GlobalData’s Pharma Intelligence Center Chinese patent authority is ranked on the top with 16,983 pharmaceutical grants issued so far in H1 2021.
spot_img

Expert Articles

spot_img